Author Topic: GH Research - private company seeking to patent a ROA  (Read 19 times)

Offline moonbeam

  • Tadpole
  • *
  • Posts: 5
  • Karma: +0/-0
    • View Profile
GH Research - private company seeking to patent a ROA
« on: February 22, 2021, 12:39:15 PM »

I was surprised to come across this private company doing a clinical study on the use of 5-MeO-DMT for treating treatment-resistant depression.  It looks like they’re seeking to patent a certain Route of Administration.  No mention of it being an adjunct to psychotherapy.

https://www.ghres.com/pipeline


GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress